PAKSOY, N. Et Al. 2022. Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study. Turk Onkoloji Dergisi , vol.37, no.4 , 478-483.

PAKSOY, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., KARABULUT, S., ... TAŞTEKİN, D.(2022). Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study. Turk Onkoloji Dergisi , vol.37, no.4, 478-483.

PAKSOY, NAİL Et Al. "Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study," Turk Onkoloji Dergisi , vol.37, no.4, 478-483, 2022

PAKSOY, NAİL Et Al. "Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study." Turk Onkoloji Dergisi , vol.37, no.4, pp.478-483, 2022

PAKSOY, N. Et Al. (2022) . "Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study." Turk Onkoloji Dergisi , vol.37, no.4, pp.478-483.

@article{article, author={NAİL PAKSOY Et Al. }, title={Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study}, journal={Turk Onkoloji Dergisi}, year=2022, pages={478-483} }